Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Ischemia | 4 | 2022 | 258 | 2.450 |
Why?
|
Stroke | 6 | 2022 | 957 | 2.350 |
Why?
|
Tissue Plasminogen Activator | 2 | 2018 | 112 | 1.150 |
Why?
|
Cerebral Hemorrhage | 4 | 2021 | 141 | 1.100 |
Why?
|
Hematoma | 3 | 2020 | 93 | 0.960 |
Why?
|
Anticoagulants | 2 | 2021 | 585 | 0.910 |
Why?
|
Space Flight | 3 | 2020 | 116 | 0.900 |
Why?
|
Brain Edema | 2 | 2021 | 69 | 0.880 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2020 | 73 | 0.790 |
Why?
|
Atrial Fibrillation | 2 | 2021 | 623 | 0.780 |
Why?
|
Diuretics, Osmotic | 1 | 2021 | 4 | 0.760 |
Why?
|
Saline Solution, Hypertonic | 1 | 2021 | 20 | 0.760 |
Why?
|
Mannitol | 1 | 2021 | 48 | 0.750 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2021 | 256 | 0.750 |
Why?
|
Glasgow Coma Scale | 2 | 2020 | 203 | 0.670 |
Why?
|
Common Data Elements | 1 | 2019 | 6 | 0.670 |
Why?
|
Neurology | 1 | 2021 | 108 | 0.660 |
Why?
|
Aneurysm, Ruptured | 1 | 2019 | 36 | 0.650 |
Why?
|
Percutaneous Coronary Intervention | 1 | 2021 | 223 | 0.570 |
Why?
|
Fibrinolytic Agents | 1 | 2018 | 199 | 0.550 |
Why?
|
Time-to-Treatment | 1 | 2018 | 187 | 0.550 |
Why?
|
Thrombolytic Therapy | 1 | 2018 | 203 | 0.540 |
Why?
|
Secondary Prevention | 1 | 2016 | 210 | 0.490 |
Why?
|
Coronary Artery Disease | 1 | 2021 | 743 | 0.470 |
Why?
|
Thrombectomy | 2 | 2021 | 102 | 0.350 |
Why?
|
Adaptation, Physiological | 3 | 2020 | 265 | 0.340 |
Why?
|
Safe Sex | 1 | 2009 | 16 | 0.340 |
Why?
|
Condoms | 1 | 2009 | 48 | 0.340 |
Why?
|
Sexual Partners | 1 | 2009 | 85 | 0.330 |
Why?
|
Object Attachment | 1 | 2009 | 52 | 0.320 |
Why?
|
Sexually Transmitted Diseases | 1 | 2009 | 94 | 0.320 |
Why?
|
History, 20th Century | 2 | 2021 | 385 | 0.300 |
Why?
|
Intracranial Pressure | 2 | 2019 | 180 | 0.270 |
Why?
|
Blood Pressure | 3 | 2020 | 1317 | 0.260 |
Why?
|
Humans | 18 | 2022 | 122853 | 0.230 |
Why?
|
Middle Aged | 8 | 2022 | 25798 | 0.200 |
Why?
|
Checklist | 1 | 2022 | 86 | 0.200 |
Why?
|
History, 18th Century | 1 | 2021 | 69 | 0.190 |
Why?
|
Treatment Outcome | 3 | 2021 | 12070 | 0.180 |
Why?
|
History, 19th Century | 1 | 2021 | 118 | 0.180 |
Why?
|
Risk Factors | 5 | 2021 | 9928 | 0.180 |
Why?
|
Vasospasm, Intracranial | 1 | 2020 | 18 | 0.170 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 169 | 0.170 |
Why?
|
Brain | 3 | 2020 | 2961 | 0.170 |
Why?
|
Vasoconstriction | 1 | 2020 | 104 | 0.170 |
Why?
|
National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2019 | 8 | 0.170 |
Why?
|
Risk Assessment | 2 | 2021 | 3316 | 0.170 |
Why?
|
National Library of Medicine (U.S.) | 1 | 2019 | 5 | 0.170 |
Why?
|
Astronauts | 1 | 2019 | 50 | 0.160 |
Why?
|
Hyponatremia | 1 | 2020 | 70 | 0.160 |
Why?
|
Sodium | 1 | 2020 | 290 | 0.160 |
Why?
|
Vision, Ocular | 1 | 2019 | 123 | 0.160 |
Why?
|
Magnesium | 1 | 2019 | 121 | 0.160 |
Why?
|
Texas | 3 | 2020 | 3542 | 0.150 |
Why?
|
Intracranial Aneurysm | 1 | 2019 | 93 | 0.150 |
Why?
|
Cost Savings | 1 | 2018 | 69 | 0.150 |
Why?
|
Spectrum Analysis | 1 | 2018 | 62 | 0.150 |
Why?
|
Single-Blind Method | 1 | 2018 | 233 | 0.150 |
Why?
|
Neurophysiological Monitoring | 1 | 2018 | 37 | 0.150 |
Why?
|
Quality Improvement | 1 | 2022 | 621 | 0.140 |
Why?
|
Aged | 6 | 2021 | 18917 | 0.140 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 731 | 0.140 |
Why?
|
Prognosis | 3 | 2020 | 4498 | 0.140 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 1033 | 0.130 |
Why?
|
Retrospective Studies | 5 | 2021 | 15927 | 0.130 |
Why?
|
Warfarin | 1 | 2016 | 120 | 0.130 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2015 | 109 | 0.130 |
Why?
|
Hospital Mortality | 1 | 2020 | 1000 | 0.120 |
Why?
|
Stents | 1 | 2021 | 867 | 0.120 |
Why?
|
Intracranial Hypertension | 1 | 2015 | 119 | 0.120 |
Why?
|
Hospitalization | 1 | 2022 | 1731 | 0.120 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 498 | 0.110 |
Why?
|
Biomedical Research | 1 | 2019 | 510 | 0.110 |
Why?
|
Patient Education as Topic | 1 | 2016 | 439 | 0.110 |
Why?
|
Male | 8 | 2021 | 59866 | 0.100 |
Why?
|
Nervous System Diseases | 1 | 2015 | 373 | 0.100 |
Why?
|
Endarterectomy, Carotid | 1 | 2012 | 92 | 0.100 |
Why?
|
Female | 8 | 2021 | 65278 | 0.100 |
Why?
|
Carotid Stenosis | 1 | 2012 | 133 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2018 | 842 | 0.090 |
Why?
|
Prospective Studies | 2 | 2018 | 5996 | 0.090 |
Why?
|
Kidney Failure, Chronic | 1 | 2018 | 866 | 0.090 |
Why?
|
Cross-Sectional Studies | 2 | 2015 | 3319 | 0.060 |
Why?
|
United States | 1 | 2019 | 10538 | 0.060 |
Why?
|
Adult | 4 | 2020 | 28926 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2012 | 3001 | 0.040 |
Why?
|
Biomarkers | 2 | 2020 | 2947 | 0.040 |
Why?
|
Animals | 1 | 2021 | 33923 | 0.040 |
Why?
|
Choroid Diseases | 1 | 2019 | 21 | 0.040 |
Why?
|
Surveys and Questionnaires | 1 | 2009 | 3641 | 0.040 |
Why?
|
Area Under Curve | 1 | 2020 | 309 | 0.040 |
Why?
|
Papilledema | 1 | 2019 | 78 | 0.040 |
Why?
|
Proof of Concept Study | 1 | 2018 | 29 | 0.040 |
Why?
|
Clinical Decision-Making | 1 | 2020 | 266 | 0.040 |
Why?
|
Osmolar Concentration | 1 | 2018 | 173 | 0.040 |
Why?
|
Vision Disorders | 1 | 2019 | 212 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 358 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 574 | 0.040 |
Why?
|
Adolescent | 2 | 2015 | 19037 | 0.030 |
Why?
|
Spinal Puncture | 1 | 2015 | 53 | 0.030 |
Why?
|
Intraocular Pressure | 1 | 2015 | 144 | 0.030 |
Why?
|
ROC Curve | 1 | 2015 | 552 | 0.030 |
Why?
|
Age Factors | 1 | 2020 | 2796 | 0.030 |
Why?
|
Incidence | 1 | 2020 | 3033 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 2047 | 0.020 |
Why?
|
Time Factors | 1 | 2020 | 6202 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2020 | 6325 | 0.020 |
Why?
|
Young Adult | 1 | 2015 | 8826 | 0.010 |
Why?
|